Study of the Academic and Professional Course of Narcoleptic Patients (NARCOSCOL-NARCOVITAE)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1605 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-27

Study Completion Date

2023-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Narcolepsy is a chronic, disabling, and rare sleep disorder (prevalence 1/2500) characterized by excessive daytime sleepiness and, in some patients, falls in muscle tone related to emotions (cataplexies). It often begins in childhood or in young adults. Symptoms of narcolepsy are responsible for an important handicap in everyday life, and are often misunderstood by the family and professional environment. In addition, many comorbidities are associated with narcolepsy, such as depression, anxiety, or obesity.

Few studies have investigated the impact of narcolepsy on patients' academic background, socio-professional integration, and quality of life.

Narcoleptic patients may experience more difficulties in their academic and professional path than non-narcoleptic people. These difficulties would be multifactorial (related to the disease itself, comorbidities, external factors ...).

As a better understanding of these determinants could help to inform patients and guide them in their choices, this study propose to establish a comprehensive inventory of educational and professional trajectories of narcoleptic patients in France in order assess the specificity of the difficulties encountered by the people concerned in their life course and to appreciate the attitude of the academic and professional circle with respect to the disease.

This category 3 study (according to the French law "Loi Jardé") is based on the case-control model and will be conducted in all National Reference and Competence Centers for Narcolepsy and Hypersomnia. It will include a population of adult and paediatric patients. It will answer questions about work and schooling in these patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pediatric Cohort Study

NCT04561427

Narcolepsy in Children

UNKNOWN

Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy

NCT05460052

Narcolepsy Type 1

COMPLETED

A Study to Collect Information of People With Narcolepsy in Spain

NCT04667338

Narcolepsy

COMPLETED

Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia

NCT05773872

Narcolepsy Social Cognition

UNKNOWN NA

Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population

NCT06292598

Narcolepsy Type 1 Bacterial Translocation

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Narcolepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult Case Group

Adults with type 1 narcolepsy according to the ICSD3

Questionnaire (Adult)

Intervention Type OTHER

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the distribution of socio-professional categories.

Answering the questionnaires will take 45 minutes.

Adult Control Group

Parents, cousins and / or friends of included narcoleptic adult patients, at least 18 years old and not suffering from narcolepsy.

Questionnaire (Adult)

Intervention Type OTHER

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the distribution of socio-professional categories.

Answering the questionnaires will take 45 minutes.

Children Case Group

Children with type 1 narcolepsy according to the OCSD3

Questionnaire (Children)

Intervention Type OTHER

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the proportion of subjects having repeated grades.

Answering the questionnaires will take 45 minutes.

Children Control Group

Close friends and cousins of included narcoleptic children, minor and not suffering from narcolepsy.

Questionnaire (Children)

Intervention Type OTHER

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the proportion of subjects having repeated grades.

Answering the questionnaires will take 45 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire (Adult)

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the distribution of socio-professional categories.

Answering the questionnaires will take 45 minutes.

Intervention Type OTHER

Questionnaire (Children)

Patients and case control will have to respond to the study questionnaire on the online entry platform to compare the proportion of subjects having repeated grades.

Answering the questionnaires will take 45 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The case group:

* Children (6 years \<age \<18 years) or adults with type 1 narcolepsy diagnosed on:
* a clinic in favor of narcolepsy: excessive daytime sleepiness lasting for more than 3 months.
* cataplexy and an positive multiple sleep latency test (mean sleep latency ≤ 8 min and ≥ 2 SOREM) or a hypocretin dosage in the CSF \<110pg / L.
* Patients followed in one of the centers participating in the research.

The control group:

* At least one person close to the case (cousins, close friends ...).
* For adults: same sex as the case and if possible same age (+/- 5 years).
* For minors: same sex and if possible same age (+/- 2 years).
* Person not suffering from narcolepsy.

Exclusion Criteria

The case group:

* Patients refusing to participate.
* Patients who do not speak the French language (incompatible with the reading, the comprehension and the filling of the questionnaires).
* Patients whose diagnosis of type 1 narcolepsy is not certain and / or has type 2 narcolepsy.
* Patients with narcolepsy symptomatic of another neurological disease.

The group controls:

* Person refusing to participate.
* Person who does not speak French (incompatible with reading, understanding and filling out questionnaires).
* The brothers and sisters of the case cannot be witnesses of the study.

Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes